Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 11/20 | 0.39 |
| ▸ | DCTPP1 | Q9H773 | 2/20 | 0.39 |
| ▸ | SCD | O00767 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11902390 | 0.86 | MAPK1 (0.42) | MAPK1P2RX7 | |
| SCHEMBL11902750 | 0.84 | MAPK1 (0.42) | MAPK1P2RX7 | |
| SCHEMBL11901567 | 0.81 | MAPK1 (0.43) | MAPK1P2RX7 | |
| SCHEMBL11902225 | 0.81 | PSEN1 (0.43) | MAPK1P2RX7 | |
| SCHEMBL11902417 | 0.80 | MAPK1 (0.43) | MAPK1P2RX7 | |
| SCHEMBL11902884 | 0.78 | P2RX7 (0.40) | MAPK1P2RX7 | |
| SCHEMBL6920222 | 0.77 | PSEN1 (0.42) | P2RX7 | |
| SCHEMBL6920482 | 0.76 | P2RX7 (0.43) | MAPK1P2RX7 | |
| SCHEMBL11902403 | 0.75 | P2RX7 (0.38) | MAPK1P2RX7 | |
| SCHEMBL11902167 | 0.74 | PSEN1 (0.46) | MAPK1P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120202787-A1 | Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators | PFIZER INC. | 2012-08-09 | — | — | US | claimed |
| US-20120202787-A1 | Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators | PFIZER INC. | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202787-A1 | Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators | BACE1, BACE2, GSAP | MAPK1 3698/4885P2RX7 2079/4885DCTPP1 3300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.